Ann: First $A9M sales month and $A10M revenue month, page-143

Hi nraw

When it comes to company valuation estimates, calculation of sales trajectories and share price predictions there are other posters here much better placed than me to offer a more meaningful contribution to the discussion.

My focus is simple - research a company, broadly and deeply, and then try to stay on top of that. I don’t trade in and out and I certainly don’t sweat the day-to-day share price movement. The ASX sector I happen to be attracted to is biotech, which some would argue makes me certifiable!

The opinion I have formed from my research is that PolyNovo is a rare biotech gem. I’ve been here from the start, am happy with sales progress to date and am confident of solid sales growth for the foreseeable future. That’s enough for me. I don’t feel the need to put specific numbers on it.

My confidence in continuing solid sales growth isn’t based on ignorance, laziness or any cavalier disregard for financial measures. It’s based on the many important signs I see from my research (and that of others here).